Frontiers in Endocrinology

Advances in the management of obesity: non-pharmacological strategies, herbal formulations, current pharmacotherapy, emerging drugs, and future perspectives

By Kaushal Navanath Mehetre, Jayshree Shriram Dawane

Figure 1. Pathophysiology of obesity. — Figure 1. Pathophysiology of obesity.Pathophysiology of obesity.Mehetre et al.

ReviewInterventions

The paper

Kaushal Navanath Mehetre, Jayshree Shriram Dawane

Bharati Vidyapeeth (Deemed to be University)

Frontiers in Endocrinology, 7 Sep 2026

doi.org/10.3389/fendo.2026.1933913 PubMed 42769318

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity